Response Genetics, Inc
OTC: RGDXQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Thomas Bologna
- Employees
- 96
- Headquarters
- Los Angeles, United States
- IPO year
- 2007
- Market cap
- $3.9K
- Website
- https://www.responsegenetics.com
Loading RGDXQ…
Loading profile data…Frequently asked questions about RGDXQ
What does Response Genetics, Inc (RGDXQ) do?
Response Genetics, Inc., a life sciences company founded in Los Angeles, California, in 1999 (originally Bio Type, Inc., before its rebranding in August 2000), focuses on creating, advancing, and commercializing pharmacogenomic tests. These diagnostic tools are crucial for informing cancer treatment decisions by assessing specific indicators wit...
Where does RGDXQ trade?
Response Genetics, Inc (RGDXQ) trades on the Other OTC.
What sector is RGDXQ in?
Response Genetics, Inc (RGDXQ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Response Genetics, Inc?
Thomas Bologna is the chief executive officer of Response Genetics, Inc (RGDXQ).
Where is Response Genetics, Inc headquartered?
Response Genetics, Inc is headquartered in United States.
Does RGDXQ pay a dividend?
Response Genetics, Inc (RGDXQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RGDXQ go public?
Response Genetics, Inc (RGDXQ) completed its initial public offering in 2007.